Comments

Gossamer Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Gossamer Bio (GOSS) operate in?

Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GOSSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.04

At close: May 16, 7:29 PM EDT

$1.03

-0.01-0.96%

After Hours: May 16, 7:29 PM EDT

Q1 2025 Earnings were released on Thu May 15th, after the market close

The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast

Gossamer Bio (GOSS) Forecast

News Earnings Gossamer Bio (GOSS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Gossamer Bio Stock Price, Quotes and Forecasts | NASDAQ:GOSS | Benzinga

Explore Gossamer Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GOSS.

Open	-
Close	-
Volume / Avg.	0 / 1.63M
Day Range	- - -
52 Wk Range	0.50 - 1.55
Market Cap	$234.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	4.56%
Days to Cover	5.9

Recent News

Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says

Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets.

Vandana Singh

Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying

Avi Kapoor

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.63M
Day Range	- - -
52 Wk Range	0.50 - 1.55
Market Cap	$234.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	4.56%
Days to Cover	5.9

About Gossamer Bio Inc

Sector

Health Care

Industry

Biotechnology

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Gossamer Bio (GOSS) stock?

You can purchase shares of Gossamer Bio (NASDAQ:GOSS) through any online brokerage.

View our list of the best stock brokerages

Who are Gossamer Bio (GOSS) competitors?

Other companies in Gossamer Bio’s space includes: Inozyme Pharma (NASDAQ:INZY), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), aTyr Pharma (NASDAQ:ATYR) and Neurogene (NASDAQ:NGNE).

What is the forecast, or price target, for Gossamer Bio (GOSS) stock?

Gossamer Bio has a consensus price target of $7.04.

What is the current price for Gossamer Bio (GOSS)?

The stock price for Gossamer Bio (NASDAQ: GOSS) is $1.03 last updated May 16, 2025 at 7:29 PM EDT.

Does Gossamer Bio (GOSS) pay a dividend?

There are no upcoming dividends for Gossamer Bio.

When is Gossamer Bio (NASDAQ:GOSS) reporting earnings?

Gossamer Bio’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Gossamer Bio (GOSS) going to split?

There is no upcoming split for Gossamer Bio.

What sector and industry does Gossamer Bio (GOSS) operate in?

Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.